There are 3161 resources available
1214P - Imaging AI prognosis of early stage lung cancer using CT radiomics
Presenter: Ann Valter
Session: Poster session 04
1215P - United Kingdom (UK) real world study of adjuvant osimertinib in resected EGFR mutated lung cancer
Presenter: Raghad Elghadi
Session: Poster session 04
1216P - Adjuvant pembrolizumab therapy for completely resected stage I NSCLC with micropapillary or solid histological subtype
Presenter: Se-Hoon Lee
Session: Poster session 04
1217P - B cell infiltration and memory TOX+ CD8+ T cells in stage I-II non-small cell lung cancer (NSCLC) predict response to neoadjuvant pembrolizumab: A phase I study
Presenter: Jair Bar
Session: Poster session 04
1218P - FALCONS, a non-interventional retrospective study in resected NSCLC patients using the EPITHOR database, first analysis
Presenter: Marie Wislez
Session: Poster session 04
1219P - Integrating artificial intelligence (AI)-based lymphocytic infiltration assessment in early stage NSCLC: A sub-study of the TNM-I trial
Presenter: Falah Jabar
Session: Poster session 04
1220P - A phase III randomized trial investigating preventive effects of perioperative landiolol, a selective beta1 blocker, on the reduction of recurrence of completely resected NSCLC
Presenter: Yasuhiro Hida
Session: Poster session 04
1221P - Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
Presenter: Gustavo Schvartsman
Session: Poster session 04
1222P - Predicting pathological complete response to neoadjuvant chemoimmunotherapy in resected NSCLC with radiomic signatures
Presenter: Mohammadhadi Khorrami
Session: Poster session 04
Resources:
Abstract
1223P - Sex specific efficacy and safety outcomes in operable stage III non-small cell lung cancer (NSCLC): Pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14
Presenter: Lorenz Frehner
Session: Poster session 04